Immunoassay Market Size to Worth US$ 51.33 Billion By 2032

According to the new research report published by Precedence Research, titled “Immunoassay Market (By Product: Reagents & Kits, Analyzer, Software and Services; By Technology: ELISA, Rapid Tests, ELISpot, Western Blotting, Radioimmunoassay; By Specimen: Blood, Saliva, Urine, Other; By Application: Infectious diseases, Endocrinology, Oncology, Bone And Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening; By End User) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032 (By Product: Traditional, Advanced; By Application: Pottery, Tiles, Abrasives, Sanitary wave, Bricks & pipes, Others; By End User: Medical, Industrial, Building & Construction, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032”, the global immunoassay market size is expected to be worth around US$ 51.33  billion by 2032 and is poised to record a yearly growth rate of 4.68% from 2023 to 2032. The study investigates several elements and their consequences on the growth of the all-wheel drive market.

This report focuses on immunoassay market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall immunoassay market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.

 The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2557

The study also provides important advancements in organic and inorganic growth strategies in the worldwide immunoassay market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of immunoassay market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.

Immunoassay Market  Report Scope 

Also read: Sensor Market Size to Worth US$ 508.64 Billion By 2032

Market Key Players

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the immunoassay market.

Some of the prominent players in the immunoassay market include

• Abbott Laboratories
• Danaher Corporation (Beckman Coulter)
• Quidel Corporation
• Ortho Clinical Diagnostics
• Sysmex Corporation
• Bio-Rad Laboratories, Inc.
• Becton, Dickinson, and Company
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific, Inc.
• Siemens Healthinners

Immunoassay Market Segmentations 

By Product

• Reagents & Kits
  • ELISA Reagents & Kits
  • Rapid Test Reagent & Kits
  • ELISpot Reagents & Kits
  • Western Blot Reagents & Kits
  • Other Reagents & Kits
• Analyzer
  • By Type
    • Open-ended System
    • Closed-Ended System
  • By Purchased Mode
    • Rental Purchased
    • Outright Purchased
• Software and Services

By Technology

• ELISA
  • By generation
    • Third generation & Above
    • Second-generation & Below
• Rapid Tests
• ELISpot
• Western Blotting
• Radioimmunoassay
• Other technologies

By Specimen

• Blood
• Saliva
• Urine
• Other Specimen

By Application

• Infectious diseases
• Endocrinology
• Oncology
• Bone and mineral disorders
• Cardiology
• Blood screening
• Autoimmune Disorders
• Allergy Diagnostics
• Toxicology
• Newborn Screening
• Other Application

By End-User

• Hospitals & Clinics
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies And Cro
• Blood Banks
• Research & Academic Laboratories
• Home Care Setting

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

Report Objectives 

• To define, segment, and project the global market size for immunoassay market
• To understand the structure of the market by identifying its various sub-segments
• To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To analyse the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
• To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
• To profile key players and comprehensively analyse their core competencies
• To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
• To analyse the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements 

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Immunoassay Market 

5.1. COVID-19 Landscape: Immunoassay Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Immunoassay Market, By Product

8.1. Immunoassay Market, by Product, 2023-2032

8.1.1. Reagents & Kits

8.1.1.1. Market Revenue and Forecast (2023-2032)

8.1.2. Analyzer

8.1.2.1. Market Revenue and Forecast (2023-2032)

8.1.3. Software and Services

8.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 9. Global Immunoassay Market, By Technology

9.1. Immunoassay Market, by Technology, 2023-2032

9.1.1. ELISA

9.1.1.1. Market Revenue and Forecast (2023-2032)

9.1.2. Rapid Tests

9.1.2.1. Market Revenue and Forecast (2023-2032)

9.1.3. ELISpot

9.1.3.1. Market Revenue and Forecast (2023-2032)

9.1.4. Western Blotting

9.1.4.1. Market Revenue and Forecast (2023-2032)

9.1.5. Radioimmunoassay

9.1.5.1. Market Revenue and Forecast (2023-2032)

9.1.6. Other technologies

9.1.5.1. Market Revenue and Forecast (2023-2032)

Chapter 10. Global Immunoassay Market, By Specimen 

10.1. Immunoassay Market, by Specimen, 2023-2032

10.1.1. Blood

10.1.1.1. Market Revenue and Forecast (2023-2032)

10.1.2. Saliva

10.1.2.1. Market Revenue and Forecast (2023-2032)

10.1.3. Urine

10.1.3.1. Market Revenue and Forecast (2023-2032)

10.1.4. Other Specimen

10.1.4.1. Market Revenue and Forecast (2023-2032)

Chapter 11. Global Immunoassay Market, By Application

11.1. Immunoassay Market, by Application, 2023-2032

11.1.1. Infectious diseases

11.1.1.1. Market Revenue and Forecast (2023-2032)

11.1.2. Endocrinology

11.1.2.1. Market Revenue and Forecast (2023-2032)

11.1.3. Oncology

11.1.3.1. Market Revenue and Forecast (2023-2032)

11.1.4. Bone and mineral disorders

11.1.4.1. Market Revenue and Forecast (2023-2032)

11.1.5. Cardiology

11.1.5.1. Market Revenue and Forecast (2023-2032)

11.1.6. Blood screening

11.1.6.1. Market Revenue and Forecast (2023-2032)

11.1.7. Autoimmune Disorders

11.1.7.1. Market Revenue and Forecast (2023-2032)

11.1.8. Allergy Diagnostics

11.1.8.1. Market Revenue and Forecast (2023-2032)

11.1.9. Toxicology

11.1.9.1. Market Revenue and Forecast (2023-2032)

11.1.10. Newborn Screening

11.1.10.1. Market Revenue and Forecast (2023-2032)

11.1.11. Other Application

11.1.11.1. Market Revenue and Forecast (2023-2032)

Chapter 12. Global Immunoassay Market, By End-User

12.1. Immunoassay Market, by End-User, 2023-2032

12.1.1. Hospitals & Clinics

12.1.1.1. Market Revenue and Forecast (2023-2032)

12.1.2. Clinical Laboratories

12.1.2.1. Market Revenue and Forecast (2023-2032)

12.1.3. Pharmaceutical & Biotechnology Companies And Cro

12.1.3.1. Market Revenue and Forecast (2023-2032)

12.1.4. Blood Banks

12.1.4.1. Market Revenue and Forecast (2023-2032)

12.1.5. Research & Academic Laboratories

12.1.5.1. Market Revenue and Forecast (2023-2032)

12.1.6. Home Care Setting

12.1.6.1. Market Revenue and Forecast (2023-2032)

Chapter 13. Global Immunoassay Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2023-2032)

13.1.2. Market Revenue and Forecast, by Technology (2023-2032)

13.1.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.1.4. Market Revenue and Forecast, by Application (2023-2032)

13.1.5. Market Revenue and Forecast, by End-User (2023-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.1.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.1.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.1.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.1.6.5. Market Revenue and Forecast, by End-User (2023-2032)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product (2023-2032)

13.1.7.2. Market Revenue and Forecast, by Technology (2023-2032)

13.1.7.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.1.7.4. Market Revenue and Forecast, by Application (2023-2032)

13.1.7.5. Market Revenue and Forecast, by End-User (2023-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.4. Market Revenue and Forecast, by Application (2023-2032)

13.2.5. Market Revenue and Forecast, by End-User (2023-2032)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.7. Market Revenue and Forecast, by Application (2023-2032)

13.2.8. Market Revenue and Forecast, by End-User (2023-2032)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.9.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.9.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.10. Market Revenue and Forecast, by Application (2023-2032)

13.2.11. Market Revenue and Forecast, by End-User (2023-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.12.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.12.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.12.4. Market Revenue and Forecast, by Application (2023-2032)

13.2.13. Market Revenue and Forecast, by End-User (2023-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.14.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.14.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.14.4. Market Revenue and Forecast, by Application (2023-2032)

13.2.15. Market Revenue and Forecast, by End-User (2023-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.5. Market Revenue and Forecast, by End-User (2023-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.7. Market Revenue and Forecast, by End-User (2023-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.8.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.8.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.8.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.9. Market Revenue and Forecast, by End-User (2023-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.10.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.10.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.10.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.10.5. Market Revenue and Forecast, by End-User (2023-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.11.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.11.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.11.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.11.5. Market Revenue and Forecast, by End-User (2023-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.5. Market Revenue and Forecast, by End-User (2023-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.7. Market Revenue and Forecast, by End-User (2023-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.8.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.8.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.8.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.9. Market Revenue and Forecast, by End-User (2023-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.10.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.10.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.10.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.10.5. Market Revenue and Forecast, by End-User (2023-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.11.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.11.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.11.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.11.5. Market Revenue and Forecast, by End-User (2023-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2023-2032)

13.5.2. Market Revenue and Forecast, by Technology (2023-2032)

13.5.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.5.4. Market Revenue and Forecast, by Application (2023-2032)

13.5.5. Market Revenue and Forecast, by End-User (2023-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.5.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.5.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.5.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.5.7. Market Revenue and Forecast, by End-User (2023-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2023-2032)

13.5.8.2. Market Revenue and Forecast, by Technology (2023-2032)

13.5.8.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.5.8.4. Market Revenue and Forecast, by Application (2023-2032)

13.5.8.5. Market Revenue and Forecast, by End-User (2023-2032)

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Danaher Corporation (Beckman Coulter)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Quidel Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Ortho Clinical Diagnostics

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Sysmex Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Bio-Rad Laboratories, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Becton, Dickinson, and Company

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. F. Hoffmann-La Roche AG

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Thermo Fisher Scientific, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Siemens Healthinners

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global immunoassay market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for immunoassay are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

 

 

---